If you’ve ever scrolled though the comments on a celebrity’s Instagram page, you’ve surely noticed that they all have one thing in common: thousand of users posting the letters “LB” without any ...

LB Pharmaceuticals aims to show that what is old can become new again with a lead drug candidate that’s a modified version of a decades-old schizophrenia medication from Sanofi. The strategy is ...

This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. LB Pharmaceuticals raised $285 million in an initial ...

As COVID-19 cases continue to rise across the United States, scientists are monitoring the spread of a new variant called LB.1. The highly contagious omicron subvariant, along with the fast-growing ...

Despite the stagnant biotech IPO market of the last six months, LB Pharmaceuticals has set out plans to reel in hundreds of millions of dollars through its upcoming public debut. The ...

There are no signs so far that the new LB.1 variant is causing more severe disease in COVID-19 patients, the Centers for Disease Control and Prevention says, as infections have begun to accelerate in ...

LB Pharmaceuticals’ decision to break cover and go public seems to have paid off, with the company bumping up the number of shares on offer for its Nasdaq listing this morning. The CNS-focused biotech ...